π©Ί Clinical Approach to Recurrent Infections: When to Suspect Immunodeficiency
πΉ Step 1: Identify red flags for primary immunodeficiency (Jeffrey Modell Foundation)
β’ β₯8 new ear infections in 1 year
β’ β₯2 serious sinus infections in 1 year
β’ β₯2 pneumonias in 1 year
β’ Recurrent deep skin or organ abscesses
β’ Persistent thrush after age 1 year
β’ Need for IV antibiotics to clear infections
β’ Family history of PID or unexplained early deaths
πΉ Step 2: Distinguish between atopy, anatomic defects, and true immunodeficiency
β’ Atopy: clear triggers, seasonal, family history, normal growth, eosinophilia.
β’ Anatomic: localized to organ (sinuses, lungs, urinary tract), imaging abnormal.
β’ Immunodeficiency: systemic, unusual organisms, failure to thrive, recurrent systemic infections.
πΉ Step 3: Initial screening labs for suspected PID
β’ CBC with differential (absolute neutrophil count, lymphocyte count)
β’ Quantitative immunoglobulins (IgG, IgA, IgM, IgE)
β’ Specific antibody titers to vaccines (tetanus, pneumococcal, Hib)
β’ CH50 (classical complement), AH50 (alternative complement)
β’ HIV testing
β’ Newborn SCID screening (TREC assay) if available
πΉ Step 4: Advanced testing based on pattern
β’ Humoral defect: B cell subsets (flow cytometry), vaccine response (tetanus, pneumococcal)
β’ T cell defect: lymphocyte subsets (CD3, CD4, CD8, CD19, NK), mitogen proliferation
β’ Phagocyte defect: DHR (dihydrorhodamine) for CGD, CD18 expression for LAD-1
β’ Autoinflammatory: CRP/ESR during episodes, genetic testing (MEFV, MVK, NLRP3, TNFRSF1A)
πΉ Step 5: Management principles
β’ Antibiotic prophylaxis for select defects (CGD, asplenia, antibody deficiency)
β’ IVIG replacement for antibody deficiencies (XLA, CVID, X-linked agammaglobulinemia)
β’ HSCT for SCID, CGD, WAS, certain combined deficiencies
β’ IL-1 inhibitors for CAPS, DIRA, FMF if colchicine fails
β’ Avoid live vaccines in suspected T cell defects until evaluated